Abstract

UK-157,147 (systematic name (3S,4R)-[6-(3-hydroxyphenyl)sulfonyl]-2,2,3-trimethyl-4-(2-methyl-3-oxo-2,3-dihydropyridazin-6-yloxy)-3-chromanol), a potent potassium channel opener designed for rapid systemic clearance, is metabolised in vivo to a glucuronide metabolite. A standard of this metabolite of UK-157,147 was required for biological testing to confirm the absence of pharmacological activity and assay development. The glucuronide conjugate of UK-157,147 was initially synthesised using a bioreactor containing immobilised microsomes as a source of uridine 5-diphosphoglucuronyl transferase (E.C.2.4.1.17). At a later date, larger amounts of the glucuronide metabolite were synthesised by traditional organic chemistry techniques using the imidate method. The identity of the chemically and biocatalytically produced glucuronide conjugate sample was proven by LC-MS and LC-NMR-MS.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.